Johnson & Johnson (JNJ) Net Income (2009 - 2026)
Johnson & Johnson (JNJ) posted Net Income of $5.2 billion for Q1 2026, up 2.33% sequentially from $5.1 billion in Q4 2025, and down 52.4% YoY from $11.0 billion in Q1 2025.
Johnson & Johnson (JNJ) Net Income (2009 - 2026) Analysis & Trends
Johnson & Johnson (JNJ) has 17 years of Net Income data on file, last reported at $5.2 billion in Q1 2026.
- Quarterly Net Income fell 52.4% year-over-year to $5.2 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $21.0 billion (up 91.29% YoY) and the FY2023 annual result came in at $21.8 billion, up 1289.37% from the prior year.
- Net Income rose to $5.2 billion in Q1 2026 per JNJ's latest filing, from $5.1 billion in the prior quarter.
- The five-year high for Net Income was $21.7 billion in Q4 2023, with the low at -$232.0 million in Q3 2023.
- Average Net Income over 4 years is $4.3 billion, with a median of $578.0 million recorded in 2022.
- The widest YoY moves for Net Income: up 14575.0% in 2023, down 142.03% in 2023.
- Johnson & Johnson's Net Income stood at $148.0 million in 2022, then sank by 156.08% to -$83.0 million in 2023, then jumped by 6263.86% to $5.1 billion in 2025, then gained by 2.33% to $5.2 billion in 2026.
- Business Quant data shows JNJ's Net Income at $5.2 billion in Q1 2026, $5.1 billion in Q4 2025, and $5.2 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn | 7.40 Bn |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn | 5.24 Bn |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn | 697.00 Mn |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn | 833.00 Mn |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn | -4.21 Bn |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn | 1.82 Bn |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn | 2.02 Bn |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn | -13.00 Mn |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - | - |
| 10 | Biogen | 30.87 Bn | 26.59 Bn | 1.82 Bn | 319.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 29, 2026 | 5.24 Bn |
| Dec 28, 2025 | 5.12 Bn |
| Sep 28, 2025 | 5.15 Bn |
| Jun 29, 2025 | 5.54 Bn |
| Mar 30, 2025 | 11.00 Bn |
| Dec 31, 2023 | -83.00 Mn |
| Oct 1, 2023 | 21.72 Bn |
| Jul 2, 2023 | -232.00 Mn |
| Apr 2, 2023 | 423.00 Mn |
| Jan 1, 2023 | 293.00 Mn |
| Oct 2, 2022 | 148.00 Mn |
| Jul 3, 2022 | 552.00 Mn |
| Apr 3, 2022 | 578.00 Mn |
| Oct 3, 2021 | 3.67 Bn |
| Jul 4, 2021 | 6.28 Bn |
| Apr 4, 2021 | 6.20 Bn |
| Jan 3, 2021 | 1.74 Bn |
| Sep 27, 2020 | 3.55 Bn |
| Jun 28, 2020 | 3.63 Bn |
| Mar 29, 2020 | 5.80 Bn |